Lactate, a glycolysis byproduct, has been implicated in the fibrotic process, while transforming growth factor-beta 1 (TGF-β1) plays a central role in promoting fibrosis. Air pollution, particularly fine particulate matter (PM2.5), represents a significant environmental risk factor for the development of pulmonary fibrosis. However, the role of lactate and the underlying mechanisms by which it acts in PM2.5-induced pulmonary fibrosis remain poorly understood. This study aimed to identify the cell types contributing to lactate accumulation in lung tissue during PM2.5-induced pulmonary fibrosis and elucidate the mechanism by which lactate regulates TGF-β1. Seven types of lung cells from PM2.5-exposed mice were isolated using fluorescence-activated cell sorting to determine their lactate production. Immunoprecipitation and immunoblotting were performed to assess the impact of lactate on TGF-β1 stability. The effect of histone lactylation on Stub1 gene expression was investigated by chromatin immunoprecipitation assays. Macrophages exhibited elevated lactate production during PM2.5-induced pulmonary fibrosis. Elevated intracellular lactate levels in macrophages suppressed the expression of carboxyl terminus of Hsc70-interacting protein (CHIP, encoded by Stub1) via the enrichment of lactylated H3K18 at the Stub1 promoter locus. Consequently, reduced CHIP expression impeded TGF-β1 degradation, promoted enhanced TGF-β1 secretion by macrophages, and exacerbated pulmonary fibrosis symptoms. Moreover, the inhibition of lactate production significantly alleviated the pulmonary fibrosis phenotype in PM2.5-exposed mice. Elevated lactate production in macrophages induced by PM2.5 inhibits the ubiquitination and degradation of TGF-β1 through the suppression of CHIP expression, thereby enhancing TGF-β1 secretion and exacerbating pulmonary fibrosis.
6 January 2024 in Trends in Endocrinology & Metabolism
Hyperlactatemia and anemia commonly coexist and their crosstalk is a longstanding mystery with elusive mechanisms involved in physical activities, infections, cancers, and genetic disorders. For instance, hyperlactatemia leads to iron restriction by upregulating hepatic hepcidin expression. Increasing evidence also points to lactate as a crucial signaling molecule rather than merely a metabolic byproduct. Here, we discuss the mutual influence between anemia and hyperlactatemia. This opinion calls for a reconsideration of the multifaceted roles of lactate and lactylation in anemia and emphasizes the need to fill knowledge gaps, including the dose dependence of lactate's effects, its sources, and its subcellular localization.
Background. Increasing evidence reveals that iron deficiency during pregnancy causes adverse pregnancy outcomes. Thus far, the mechanisms underlying iron deficiency-associated preterm birth are mostly limited to animal studies. Whether the suggested mechanisms exist in human requires further investigation. The goal of this study was to characterize the iron metabolism in both the maternal side and fetal side in pregnant women with preterm birth. Methods. Serum and placenta samples were collected from 42 pregnant women divided into four groups according to the gestational week. Indicators of iron metabolism, including serum iron, serum hepcidin, placental tissue iron, ferroportin (FPN), transferrin receptor 1 (TfR1), and ferritin, were surveyed using enzyme-linked immunosorbent assays (Elisa), Western blots, and real-time quantitative polymerase chain reactions (qRT-PCR). Results. Significant reduction of maternal serum iron was observed in women with preterm birth relative to those with full-term birth, indicative of worsen iron deficiency in those mothers with preterm birth. Meanwhile, the maternal hepcidin levels were notably diminished in women with preterm birth, whereas the fetal hepcidin levels were comparable between the two groups. Moreover, the placental iron stores were remarkably reduced in the preterm group, associated with reduced concentration of TfR1 and increased FPN concentration relative to the normal controls. In other words, the ratio of placental FPN mass to TfR1 mass (PIDI index) was strikingly increased in the preterm group. Conclusions. Dysregulated iron homeostasis in both the maternal and fetal sides was implicated in preterm births, and disordered regulations in maintaining the placental iron equilibrium were also presumed to account for the compromised fetal iron supply.
Current iron overload therapeutics have inherent drawbacks including perpetuated low hepcidin. Here, we unveiled that lactate, a potent hepcidin agonist, effectively reduced serum and hepatic iron levels in mouse models of iron overload with an improved erythropoiesis in β-thalassemic mice.